Gene modification technologies play a vital role in the study of biological systems and pathways. Although there is widespread and beneficial use of genetic mouse models, potential shortcomings of gene targeting technology exist, and are not always taken into consideration. Oversights associated with the technology can lead to misinterpretation of results; for example, ablation of a gene of interest can appear to cause an observed phenotype when, in fact, residual embryonic stem cell-derived genetic material in the genetic background or in the area immediately surrounding the ablated gene is actually responsible.
Introduction
Gene targeting is critical to advances in many fields of research, ranging from immunology to neuroscience to genetics. This fact is evident from the prominence of knockout mouse studies in the literature (e.g., a search of ''knockout mice" yields more than 50,000 hits in PubMed). There is no denying the fact that the availability of genetic mouse models has revolutionized biomedical research; further, recently established alterations to classical gene modification techniques have made possible the generation of conditional, inducible, and even multiple-gene knockout mouse mutants. Gene-targeting technologies deliver a more informative look into the in vivo functions and endogenous expression patterns of individual genes. Thus, the promise of this technology has spurred the generation of a plethora of knockout mice with ablated genes that are involved in diverse biological pathways and systems.
It is tempting to conclude that the phenotypes observed in any given knockout mouse are completely due to the ablation of the gene of interest, and researchers often do make this assumption. In many cases, they are correct. However, as we will discuss in this review, traditional knockout technology has commonly overlooked limitations. One of these limitations is the presence of regions of genetic variability (''passenger" or ''flanking" genes) that are transported with the ''knocked out" gene onto the selected genetic background. We will highlight how these genetic regions can have a critical impact on the interpretation of phenotypic data, as illustrated in a recent behavioral study of interleukin-10 knockout mice (Rodrigues de Ledesma et al., 2006) . In addition, we will present various approaches that have been designed to abrogate flanking gene and genetic background complications and discuss modifications to conventional knockout methods that can circumvent the issue of flanking genes entirely.
Generation of a knockout mouse: strengths and limitations
Researchers must be aware of the basic principles of current gene modification technology before the inherent complications arising from flanking and/or background genes can be fully appreciated. The basic premise behind the development of a knockout mouse is to replace the normal functioning gene with one that is nonfunctional (i.e., a null mutation). The generation of a knockout mouse has been described in detail previously (Nagy et al., 2003; Papaioannou and Behringer, 2004 ) and will only be briefly reviewed here. The first step of the process is to introduce a null mutation of the gene of interest into a critical exonic sequence. This sequence is subsequently inserted into the targeting vector. In addition to the disrupted gene, another gene is included between the homologous regions. Generally, this is an antibiotic resistance gene, which will allow selection of cells in which the vector has integrated. The mutation-carrying targeting vector is introduced into embryonic stem (ES) cells (Fig. 1) , where it integrates into the genome via homologous recombination. Antibiotic resistant ES cells (those that have incorporated the mutagenized DNA construct) are then used for injection into blastocysts, which are in turn transferred into pseudopregnant females for production of mutant mice. Importantly, several 129-derived cell lines, originating from the Parental and Steel substrains (described in Section
